Status:
COMPLETED
Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborating Sponsors:
Tokyo Medical and Dental University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer who have undergone surgery and chemotherapy may help doctors predict how well patients will respond to treatment...
Detailed Description
OBJECTIVES: * Identify predictive factors of efficacy and safety of adjuvant chemotherapy comprising fluorouracil-based regimens in patients with stage III colon cancer. * Investigate possibility of ...
Eligibility Criteria
Inclusion
- \<Inclusion criteria\>
- Pathologically confirmed stage III colon adenocarcinoma
- Curatively resected (R0)
- Patients scheduled for treatment with fluorouracil-based post-operative adjuvant chemotherapy
- Provided written informed consent
- \<Exclusion criteria\>
- Synchronous or metachronous multiple cancers
- Contraindications for fluorouracil-based chemotherapy
- Patients who have initiated neo-adjuvant chemotherapy or radiotherapy prior to participating in this study
- Ineligible patients according to the investigator's judgement
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2017
Estimated Enrollment :
2128 Patients enrolled
Trial Details
Trial ID
NCT00918827
Start Date
April 1 2009
End Date
March 31 2017
Last Update
June 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo Medical and Dental University
Tokyo, Japan, 113-8519